Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting

The Nomination Committee, prior to the 2021 Annual General Meeting, comprises the following members: Laurent Leksell (Chairman), with direct and indirect holdings; Per Colleen, appointed by Fjärde AP-Fonden; Filippa Gerstädt, appointed by Nordea Fonder; Javiera Ragnartz, appointed by SEB Fonder and Tomas Risbecker, appointed by AMF and AMF Fonder. The chairman of the Nomination Committee is Laurent Leksell. The Nomination Committee, prior to the 2021 Annual General Meeting, comprises the...

The Nomination Committee, prior to the 2021 Annual General Meeting, comprises the following members: Laurent Leksell (Chairman), with direct and indirect holdings; Per Colleen, appointed by Fjärde AP-Fonden; Filippa Gerstädt, appointed by Nordea Fonder; Javiera Ragnartz, appointed by SEB Fonder and Tomas Risbecker, appointed by AMF and AMF Fonder. The chairman of the Nomination Committee is Laurent Leksell.

For further information, please contact:

Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25
e-mail: [email protected]
Time zone: CET: Central European Time

About Elekta

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/elekta-nomination-committee-s-proposed-board-of-directors-for-the-2021-annual-general-meeting,c3360611

The following files are available for download: